| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ian Bruce | Q30348366 |
| P2093 | author name string | Durrington PN | |
| Wajed J | |||
| Ahmad Y | |||
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| cardiovascular disease | Q389735 | ||
| risk factor | Q1475848 | ||
| prevention | Q1717246 | ||
| P304 | page(s) | 7-12 | |
| P577 | publication date | 2003-07-16 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management | |
| P478 | volume | 43 |
| Q36290168 | 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus |
| Q63694272 | 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol |
| Q59560053 | Arterial Stiffening, Wave Reflection, and Inflammation in Habitually Exercising Systemic Lupus Erythematosus Patients |
| Q45921228 | Aspirin resistance in systemic lupus erythematosus. A pilot study. |
| Q46879415 | Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus |
| Q36458127 | Atherogenesis in rheumatology |
| Q35525108 | Atherosclerosis in systemic lupus erythematosus |
| Q48264560 | B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance? |
| Q36835851 | Cardiovascular co-morbidity in rheumatic diseases |
| Q43061600 | Cardiovascular disease complications in systemic lupus erythematosus |
| Q38126009 | Cardiovascular risk and inflammatory rheumatic diseases |
| Q46771777 | Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting. |
| Q51196776 | Children and adolescents with SLE: not just little adults. |
| Q59341925 | Comentarios bibliográficos |
| Q28200286 | Coronary artery disease in patients with systemic lupus erythematosus |
| Q26741266 | Current and emerging treatment options in the management of lupus |
| Q37582574 | Epidemiology of atherosclerosis in systemic lupus erythematosus |
| Q34187282 | European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies |
| Q46118003 | Features associated with cardiac abnormalities in systemic lupus erythematosus |
| Q36596375 | Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus |
| Q46318778 | High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus |
| Q51651321 | Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease. |
| Q60649874 | Identification of a biological signature for schizophrenia in serum |
| Q37506250 | Intakes of vitamin B6 and dietary fiber and clinical course of systemic lupus erythematosus: a prospective study of Japanese female patients |
| Q52592135 | Lipid Testing and Statin Prescription among Medicaid Recipients with Systemic Lupus Erythematosus, Diabetes Mellitus and the General Medicaid Population. |
| Q57025142 | Lipopolysaccharide Challenge Reveals Hypothalamic-Pituitary-Adrenal Axis Dysfunction in Murine Systemic Lupus Erythematosus |
| Q37121353 | Lupus: improving long-term prognosis |
| Q34011661 | Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study |
| Q33730536 | Management of cardiovascular complications in systemic lupus erythematosus |
| Q36958317 | Mycophenolate mofetil and atherosclerosis: results of animal and human studies. |
| Q34866702 | Periodontal infection in adult-onset Still's disease patient: clinical and haematological considerations |
| Q38156069 | Pragmatic approaches to therapy for systemic lupus erythematosus |
| Q46412003 | Pravastatin, a 3-hydroxy-3-methyl-glutharyl coenzyme A inhibitor does not show pleiotropic effects in patients with systemic lupus erythematosus |
| Q39900850 | Prevalence, risk factors and outcome of digital gangrene in 2684 lupus patients |
| Q37221927 | Proximal aortic stiffness is increased in systemic lupus erythematosus activity in children and adolescents |
| Q93008976 | Quality of care predicts outcome in systemic lupus erythematosus: a cross-sectional analysis of a German long-term study (LuLa cohort) |
| Q36056947 | Risk factors for coronary heart disease in connective tissue diseases |
| Q36509296 | Short-term patient-centered nutrition counseling impacts weight and nutrient intake in patients with systemic lupus erythematosus |
| Q34363307 | Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population. |
| Q79934477 | Subclinical impairment of arterial mechanics in systemic lupus erythematosus identified by arterial waveform analysis |
| Q55933861 | Systemic lupus erythematosus |
| Q37033345 | Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention |
| Q57761129 | The Global Spine Care Initiative: public health and prevention interventions for common spine disorders in low- and middle-income communities |
| Q34299565 | The erythrocyte sedimentation rate in HIV: a neglected parameter? |
| Q39400939 | The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. |
| Q35169351 | The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus |
| Q36821493 | The role of preventive cardiology in systemic lupus erythematosus |
| Q50722036 | The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis. |
| Q28188901 | Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease |
| Q39150632 | Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. |
| Q44688452 | What do lupus specialists believe about managing conventional cardiovascular risk factors in patients with systemic lupus erythematosus? |
| Q81575733 | [Cardiovascular monitoring of patients with systemic lupus erythematosus] |
| Q84935571 | [Serum-based biomarkers for psychiatric disorders] |
Search more.